Publicaciones en colaboración con investigadores/as de Complejo Hospitalario de Toledo (70)

2023

  1. Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2517-2525

2022

  1. Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)

    Scientific Reports

  2. Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in Spain

    Pediatric Dermatology, Vol. 39, Núm. 4, pp. 557-562

2021

  1. Long-term effects of continuous subcutaneous insulin infusion in adults with type 1 diabetes mellitus patients: Results of a public healthcare system

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 2, pp. 116-122

  2. Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study

    The Lancet Haematology, Vol. 8, Núm. 3, pp. e194-e204

2020

  1. Clinical validation of risk scoring systems to predict risk of delayed bleeding after EMR of large colorectal lesions

    Gastrointestinal Endoscopy, Vol. 91, Núm. 4, pp. 868-878.e3

  2. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

  3. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Do Dermatologic Diagnosis Change in Hot vs. Cold Periods of The Year? A Sub-Analysis of the DIADERM National Sample (Spain 2016)

    Actas Dermo-Sifiliograficas, Vol. 110, Núm. 9, pp. 734-743

  2. Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion

    European Journal of Cancer, Vol. 120, pp. 54-64

  3. Femoral artery ultrasound for improving the detection of atherosclerosis in psoriasis

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 3, pp. 784-786

  4. Involvement of plasma miRNAs, muscle miRNAs and mitochondrial miRNAs in the pathophysiology of frailty

    Experimental Gerontology, Vol. 124

  5. Multicentric study on total pancreatectomies

    Cirugia Espanola, Vol. 97, Núm. 7, pp. 377-384

  6. Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study

    Breast Cancer Research and Treatment, Vol. 177, Núm. 1, pp. 115-125

  7. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 102-108

  8. Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens

    Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 459-466

  9. Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

    PLoS ONE, Vol. 14, Núm. 10

  10. Subclinical atherosclerosis in psoriasis. Usefulness of femoral artery ultrasound for the diagnosis, and analysis of its relationship with insulin resistance

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Analysis of Plasma MicroRNAs as Predictors and Biomarkers of Aging and Frailty in Humans

    Oxidative Medicine and Cellular Longevity, Vol. 2018

  2. Apremilast en el tratamiento de la psoriasis, experiencia clínica real

    Piel